Emergent BioSolutions cuts 2026 revenue and EBITDA guidance as Q3 sales fall 52%Nov 2Quarterly updateAmgenAprea Therapeutics
BMS registers Phase 1 CAR T cell trial in kidney cancer; adds mavacamten real-world studyOct 1Weekly roundup, 5 itemsBristol Myers SquibbgolcadomideUpdated
JAVELIN Bladder Medley results posted; Merck files separate MK-2010 trial across six tumor typesSep 1Weekly roundup, 2 itemsavelumabbelzutifan